Abstract
Cyclin-dependent kinase (Cdk) 5 is ubiquitously expressed in the brain and plays an essential role in central nervous system development and synaptic plasticity. The p35 kinase is a neuronal specific activator of Cdk5. Here, we show for the first time that Cdk5 activation modulates leptin signaling. P35 and its metabolite p25 were colocalized with the leptin receptor ObR in selective neurons in the hypothalamus. Overexpression of p35 alone was sufficient to induce the transcriptional activation of signal transducer and activator of transcription 3 (STAT3) in a cellular model. In retinoic acid-differentiated SH-SY5Y neuronal cells where ObRb was induced, leptin increased the expression of Cdk5, p35, and p25 kinases. The time course of induction coincided with that of phosphorylated (p)-STAT3. When Cdk5 activity was inhibited, either by roscovitine or overexpression of dominant negative Cdk5, there was a reduction of pSTAT3 activation. The results show that the activation of Cdk5 by p35 sustained leptin-induced pSTAT3 at 3–6 h. Thus, p35 is a novel modulator of leptin-induced STAT3 signaling.
Similar content being viewed by others
References
Banks, W. A., Kastin, A. J., Huang, W., Jaspan, J. B., & Maness, L. M. (1996). Leptin enters the brain by a saturable system independent of insulin. Peptides, 17, 305–311. doi:10.1016/0196-9781(96)00025-3.
Baumann, K., Mandelkow, E. M., Biernat, J., Piwnica-Worms, H., & Mandelkow, E. (1993). Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Letters, 336, 417–424. doi:10.1016/0014-5793(93)80849-P.
Benomar, Y., Roy, A. F., Aubourg, A., Djiane, J., & Taouis, M. (2005). Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line. The Biochemical Journal, 388, 929–939. doi:10.1042/BJ20041621.
Bjorbak, C., Lavery, H. J., Bates, S. H., Olson, R. K., Davis, S. M., Flier, J. S., et al. (2000). SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. The Journal of Biological Chemistry, 275, 40649–40657. doi:10.1074/jbc.M007577200.
Cheung, Z. H., Fu, A. K., & Ip, N. Y. (2006). Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases. Neuron, 50, 13–18. doi:10.1016/j.neuron.2006.02.024.
Fu, A. K., Fu, W. Y., Ng, A. K., Chien, W. W., Ng, Y. P., Wang, J. H., et al. (2004). Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America, 101, 6728–6733. doi:10.1073/pnas.0307606100.
Garris, D. R. (1989). Morphometric analysis of obesity (ob/ob)- and diabetes (db/db)-associated hypothalamic neuronal degeneration in C57BL/KsJ mice. Brain Research, 501, 162–170. doi:10.1016/0006-8993(89)91037-8.
Guo, Z., Jiang, H., Xu, X., Duan, W., & Mattson, M. P. (2008). Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. The Journal of Biological Chemistry, 283, 1754–1763. doi:10.1074/jbc.M703753200.
Harvey, J. (2007). Leptin: A diverse regulator of neuronal function. Journal of Neurochemistry, 100, 307–313. doi:10.1111/j.1471-4159.2006.04205.x.
He, Y., Li, H. L., Xie, W. Y., Yang, C. Z., Yu, A. C., & Wang, Y. (2007). The presence of active Cdk5 associated with p35 in astrocytes and its important role in process elongation of scratched astrocyte. Glia, 55, 573–583. doi:10.1002/glia.20485.
Hellmich, M. R., Pant, H. C., Wada, E., & Battey, J. F. (1992). Neuronal cdc2-like kinase: A cdc2-related protein kinase with predominantly neuronal expression. Proceedings of the National Academy of Sciences of the United States of America, 89, 10867–10871. doi:10.1073/pnas.89.22.10867.
Jang, E. H., Park, C. S., Lee, S. K., Pie, J. E., & Kang, J. H. (2007). Excessive nitric oxide attenuates leptin-mediated signal transducer and activator of transcription 3 activation. Life Sciences, 80, 609–617. doi:10.1016/j.lfs.2006.10.007.
Kastin, A. J., Banks, W. A., Zadina, J. E., & Graf, M. V. (1983). Brain peptides: The dangers of constricted nomenclatures. Life Sciences, 32, 295–301. doi:10.1016/0024-3205(3)90073-5.
Kastin, A. J., & Pan, W. (2006). Intranasal leptin: Blood–brain barrier bypass (BBBB) for obesity? Endocrinology, 147, 2086–2087. doi:10.1210/en.2006-0208.
Larsen, L., & Ropke, C. (2002). Suppressors of cytokine signalling: SOCS. APMIS, 110, 833–844. doi:10.1034/j.1600-0463.2002.1101201.x.
Levin, B. E., Dunn-Meynell, A. A., & Banks, W. A. (2004). Obesity-prone rats have normal blood–brain barrier transport but defective central leptin signaling before obesity onset. The American Journal of Physiology, 286, R143–R150.
Lew, J., Huang, Q. Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., et al. (1994). A brain-specific activator of cyclin-dependent kinase 5. Nature, 371, 423–426. doi:10.1038/371423a0.
Lew, J., Qi, Z., Huang, Q. Q., Paudel, H., Matsuura, I., Matsushita, M., et al. (1995). Structure, function, and regulation of neuronal Cdc2-like protein kinase. Neurobiology of Aging, 16, 263–268. doi:10.1016/0197-4580(95)00014-6.
Lin, H., Chen, M. C., Chiu, C. Y., Song, Y. M., & Lin, S. Y. (2007). Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. The Journal of Biological Chemistry, 282, 2776–2784. doi:10.1074/jbc.M607234200.
Meijer, L., Borgne, A., Mulner, O., Chong, J. P., Blow, J. J., Inagaki, N., et al. (1997). Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. European Journal of Biochemistry, 243, 527–536. doi:10.1111/j.1432-1033.1997.t01-2-00527.x.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., et al. (1992). A family of human cdc2-related protein kinases. The EMBO Journal, 11, 2909–2917.
O’Rourke, L., & Shepherd, P. R. (2002). Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: Role in regulating STAT3 Ser727 phosphorylation and DNA binding. The Biochemical Journal, 364, 875–879. doi:10.1042/BJ20020295.
Ohshima, T., Gilmore, E. C., Longenecker, G., Jacobowitz, D. M., Brady, R. O., Herrup, K., et al. (1999). Migration defects of cdk5(−/−) neurons in the developing cerebellum is cell autonomous. The Journal of Neuroscience, 19, 6017–6026.
Pan, W., Hsuchou, H., He, Y., Sakharkar, A., Cain, C., Yu, C., et al. (2008a). Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology, 149, 2798–2806. doi:10.1210/en.2007-1673.
Pan, W., Hsuchou, H., Tu, H., & Kastin, A. J. (2008b). Developmental changes of leptin receptors in cerebral microvessels: Unexpected relation to leptin transport. Endocrinology, 149, 877–885. doi:10.1210/en.2007-0893.
Pan, W., & Kastin, A. J. (2007a). Adipokines and the blood–brain barrier. Peptides, 28, 1317–1330. doi:10.1016/j.peptides.2007.04.023.
Pan, W., & Kastin, A. J. (2007b). Mahogany, blood–brain barrier, and fat mass surge in A(VY) mice. International Journal of Obesity, 31, 1030–1032. doi:10.1038/sj.ijo.0803536.
Pan, W., Tu, H., Hsuchou, H., Daniel, J., & Kastin, A. J. (2007). Unexpected amplification of leptin-induced Stat3 signaling by urocortin: Implications for obesity. Journal of Molecular Neuroscience, 33, 232–238. doi:10.1007/s12031-007-0071-y.
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L. H. (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 402, 615–622. doi:10.1038/45159.
Rosenblum, C. I., Tota, M., Cully, D., Smith, T., Collum, R., Qureshi, S., et al. (1996). Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology, 137, 5178–5181. doi:10.1210/en.137.11.5178.
Russo, V. C., Metaxas, S., Kobayashi, K., Harris, M., & Werther, G. A. (2004). Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology, 145, 4103–4112. doi:10.1210/en.2003-1767.
Schwartz, M. W., Woods, S. C., Porte Jr, D., Seeley, R. J., & Baskin, D. G. (2000). Central nervous system control of food intake. Nature, 404, 661–671.
Sitko, J. C., Yeh, B., Kim, M., Zhou, H., Takaesu, G., Yoshimura, A., et al. (2008). SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage. Cell Signal, 20, 2221–2230.
Tang, D., Lee, K. Y., Qi, Z., Matsuura, I., & Wang, J. H. (1996). Neuronal Cdc2-like kinase: From cell cycle to neuronal function. Biochemistry and Cell Biology, 74, 419–429.
Tsai, L. H., Delalle, I., Caviness Jr, V. S., Chae, T., & Harlow, E. (1994). p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature, 371, 419–423. doi:10.1038/371419a0.
Tsai, L. H., Takahashi, T., Caviness Jr, V. S., & Harlow, E. (1993). Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development, 119, 1029–1040.
Tseng, H. C., Zhou, Y., Shen, Y., & Tsai, L. H. (2002). A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Letters, 523, 58–62. doi:10.1016/S0014-5793(02)02934-4.
Tu, H., Kastin, A. J., Hsuchou, H., & Pan, W. (2008). Soluble receptor inhibits leptin transport. Journal of Cellular Physiology, 214, 301–305. doi:10.1002/jcp.21195.
Tu, H., Pan, W., Feucht, L., & Kastin, A. J. (2007). Convergent trafficking pattern of leptin after endocytosis mediated by ObRa–ObRd. Journal of Cellular Physiology, 212, 215–222. doi:10.1002/jcp.21020.
Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell Jr, J. E., Stoffel, M., & Friedman, J. M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nature Genetics, 14, 95–97. doi:10.1038/ng0996-95.
Veeranna, S. K. T., Takahashi, M., Grant, P., & Pant, H. C. (2000). Cdk5 and MAPK are associated with complexes of cytoskeletal proteins in rat brain. Brain Research. Molecular Brain Research, 76, 229–236. doi:10.1016/S0169-328X(00)00003-6.
Waelput, W., Verhee, A., Broekaert, D., Eyckerman, S., Vandekerckhove, J., Beattie, J. H., et al. (2000). Identification and expression analysis of leptin-regulated immediate early response and late target genes. The Biochemical Journal, 348(Pt 1), 55–61. doi:10.1042/0264-6021:3480055.
Wang, Y., Xie, W. Y., He, Y., Wang, M., Yang, Y. R., Zhang, Y., et al. (2006). Role of CDK5 in neuroprotection from serum deprivation by mu-opioid receptor agonist. Experimental Neurology, 202, 313–323. doi:10.1016/j.expneurol.2006.06.005.
Xu, L., Rensing, N., Yang, X. F., Zhang, H. X., Thio, L. L., Rothman, S. M., et al. (2008). Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. The Journal of Clinical Investigation, 118, 272–280. doi:10.1172/JCI33009.
Yan, Z., Chi, P., Bibb, J. A., Ryan, T. A., & Greengard, P. (2002). Roscovitine: A novel regulator of P/Q-type calcium channels and transmitter release in central neurons. The Journal of Physiology, 540, 761–770. doi:10.1113/jphysiol.2001.013376.
Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., et al. (2002). PTP1B regulates leptin signal transduction in vivo. Developmental Cell, 2, 489–495. doi:10.1016/S1534-5807(02)00148-X.
Zheng, M., Leung, C. L., & Liem, R. K. (1998). Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. Journal of Neurobiology, 35, 141–159. doi:10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4.
Zlokovic, B. V., Jovanovic, S., Miao, W., Samara, S., Verma, S., & Farrell, C. L. (2000). Differential regulation of leptin transport by the choroid plexus and blood–brain barrier and high affinity transport systems for entry into hypothalamus and across the blood–cerebrospinal fluid barrier. Endocrinology, 141, 1434–1441. doi:10.1210/en.141.4.1434.
Acknowledgments
This study was supported by NIH (DK54880, NS45751, NS46528, and NS62291). The Cdk5-pcDNA3.1(–) (WT-Cdk5), dominant negative (kinase inactive) D144N Cdk5-pcDNA3.1(–) (DN-Cdk5), and p35-pEGFP-C2 plasmids originated from Prof. Yun Wang’s Laboratory (Institute of Neuroscience, Peking University, Beijing, China). The ObRb-pcDNA3.1(–) plasmid was kindly provided by Dr. Christian Bjorbaek (Harvard Medical School, Boston, MA, USA) and the pAH-Luc luciferase reporter plasmid for STAT3 activation was kindly provided by Dr. Charles Rosenblum at Merck Research Laboratories (Rahway, NJ, USA). We thank Dr. George Argyropoulos in PBRC for assistance in electroporation, Loula Burton for manuscript submission, and other members of the BBB Group for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, Y., Kastin, A.J., Hsuchou, H. et al. The Cdk5/p35 Kinases Modulate Leptin-Induced STAT3 Signaling. J Mol Neurosci 39, 49–58 (2009). https://doi.org/10.1007/s12031-008-9174-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9174-3